News

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...
Novo Nordisk’s semaglutide product to lose patent protection in China next year, according to L.E.K. Consulting.
Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...